» Articles » PMID: 34057837

Knockdown of Long Non-coding RNA CCAT2 Suppresses Growth and Metastasis of Esophageal Squamous Cell Carcinoma by Inhibiting the -catenin/WISP1 Signaling Pathway

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2021 May 31
PMID 34057837
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Long non-coding RNA (lncRNA) colon cancer-associated transcript 2 (CCAT2) plays oncogenic roles in several cancers, including esophageal squamous cell carcinoma (ESCC). However, the specific mechanism of how CCAT2 influences ESCC tumorigenesis is still unknown.

Methods: Using RT-qPCR, the mRNA expression levels of CCAT2 in 33 paired ESCC and adjacent non-cancer tissues and cell lines were measured. Lentiviral vector sh-CCAT2 was designed and transfected into TE10 cells. CCK-8 and transwell assays were employed to detect the effects of CCAT2 knockdown on cell proliferation and invasion, respectively. RT-qPCR and western blots were used to detect the effects of CCAT2 knockdown.

Results: CCAT2 was overexpressed in ESCC tissues compared with corresponding adjacent tissues. CCAT2 knockdown could suppress cell proliferation and invasion . Furthermore, knockdown of CCAT2 could suppress the mRNA and protein levels of β-catenin and Wnt-induced-secreted-protein-1 (WISP1), as well as the mRNA levels of their downstream targets VEGF-A, MMP2, and ICAM-1. High expression of CCAT2 and WISP1 were associated with poor prognosis of ESCC patients.

Conclusions: In conclusion, a novel CCAT2/β-catenin/WISP1 axis was revealed in ESCC progression and may provide a promising therapeutic target against ESCC. CCAT2 and WISP1 are potential molecular biomarkers for predicting prognosis of ESCC.

Citing Articles

Knockdown of WISP1/DKK1 restrains phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition and stemness.

Fu C, Lu Z, Shi J, Liu F, Su X Clin Transl Oncol. 2024; 27(2):580-592.

PMID: 39093516 DOI: 10.1007/s12094-024-03639-6.


Matricellular proteins: Potential biomarkers in head and neck cancer.

Wang Y, Liu X, Wang X, Lu J, Tian Y, Liu Q J Cell Commun Signal. 2024; 18(2):e12027.

PMID: 38946720 PMC: 11208127. DOI: 10.1002/ccs3.12027.


An overview of CCN4 (WISP1) role in human diseases.

Singh K, Oladipupo S J Transl Med. 2024; 22(1):601.

PMID: 38937782 PMC: 11212430. DOI: 10.1186/s12967-024-05364-8.


Single Nucleotide Polymorphisms (SNPs) in the Shadows: Uncovering their Function in Non-Coding Region of Esophageal Cancer.

Saikia S, Postwala H, Athilingam V, Anandan A, Padma V, Kalita P Curr Pharm Biotechnol. 2024; 25(15):1915-1938.

PMID: 38310451 DOI: 10.2174/0113892010265004231116092802.


Long noncoding RNA LINC01088 inhibits esophageal squamous cell carcinoma progression by targeting the NPM1-HDM2-p53 axis.

Liang F, Luo Q, Han H, Zhang J, Yang Y, Chen J Acta Biochim Biophys Sin (Shanghai). 2023; 55(3):367-381.

PMID: 36942988 PMC: 10160232. DOI: 10.3724/abbs.2023021.


References
1.
Lagergren J, Smyth E, Cunningham D, Lagergren P . Oesophageal cancer. Lancet. 2017; 390(10110):2383-2396. DOI: 10.1016/S0140-6736(17)31462-9. View

2.
Saha S, Kiran M, Kuscu C, Chatrath A, Wotton D, Mayo M . Long Noncoding RNA DRAIC Inhibits Prostate Cancer Progression by Interacting with IKK to Inhibit NF-κB Activation. Cancer Res. 2020; 80(5):950-963. PMC: 7056510. DOI: 10.1158/0008-5472.CAN-19-3460. View

3.
Anderson D, Anderson K, Chang C, Makarewich C, Nelson B, McAnally J . A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell. 2015; 160(4):595-606. PMC: 4356254. DOI: 10.1016/j.cell.2015.01.009. View

4.
Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis R . CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013; 23(9):1446-61. PMC: 3759721. DOI: 10.1101/gr.152942.112. View

5.
Bhan A, Soleimani M, Mandal S . Long Noncoding RNA and Cancer: A New Paradigm. Cancer Res. 2017; 77(15):3965-3981. PMC: 8330958. DOI: 10.1158/0008-5472.CAN-16-2634. View